Meyd-773 (720p)

Title:
MEYD‑773: A Novel Small‑Molecule Inhibitor of the PI3K/AKT Pathway with Potent Activity against Triple‑Negative Breast Cancer

Objective: To characterize the pharmacological profile, mechanism of action, and in‑vivo efficacy of MEYD‑773, a newly synthesized heterocyclic scaffold designed to selectively inhibit class I PI3K isoforms. MEYD-773

¹Department of Pharmacology, University of Cambridge, Cambridge, UK
²Institute of Chemical Biology, National University of Singapore, Singapore
³Center for Cancer Research, Universidad Nacional Autónoma de México, Mexico City, Mexico
⁴Division of Oncology, Seoul National University Hospital, Seoul, South Korea Title: MEYD‑773: A Novel Small‑Molecule Inhibitor of the

The Future of Adult Entertainment and MEYD-773 mechanism of action